Direct from the pipeline: results of phase I and II studies of new drugs

doi:10.3109/9780203010778-53

ABSTRACT

Increased insight into the biology of prostate cancer coupled with the emergence of new therapeutic strategies has altered the nihilist approach that has often been adopted for patients with advanced prostate cancer.